A detailed history of Emerald Advisers, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,960,659 shares of TVTX stock, worth $36 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
1,960,659
Previous 1,637,146 19.76%
Holding current value
$36 Million
Previous $13.5 Million 103.83%
% of portfolio
1.14%
Previous 0.6%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$7.89 - $15.21 $2.55 Million - $4.92 Million
323,513 Added 19.76%
1,960,659 $27.4 Million
Q2 2024

Aug 06, 2024

SELL
$5.26 - $8.28 $590,461 - $929,471
-112,255 Reduced 6.42%
1,637,146 $13.5 Million
Q1 2024

May 08, 2024

BUY
$7.18 - $9.82 $5.05 Million - $6.91 Million
703,252 Added 67.22%
1,749,401 $13.5 Million
Q4 2023

Feb 05, 2024

SELL
$5.44 - $9.5 $76,992 - $134,453
-14,153 Reduced 1.33%
1,046,149 $9.4 Million
Q3 2023

Oct 26, 2023

BUY
$7.64 - $17.25 $3.19 Million - $7.2 Million
417,250 Added 64.89%
1,060,302 $9.48 Million
Q2 2023

Jul 25, 2023

BUY
$15.3 - $22.61 $9.84 Million - $14.5 Million
643,052 New
643,052 $9.88 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.18B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.